Many Not Treated According to 2013 Cholesterol Guidelines

Share this content:
Many Not Treated According to 2013 Cholesterol Guidelines
Many Not Treated According to 2013 Cholesterol Guidelines

TUESDAY, Nov. 25, 2014 (HealthDay News) -- Many patients are not being treated in accordance with the 2013 American College of Cardiology/America Heart Association (ACC/AHA) cholesterol guidelines, according to a study published in the Dec. 2 issue of the Journal of the American College of Cardiology.

Thomas M. Maddox, M.D., from the VA Eastern Colorado Health Care System in Denver, and colleagues examined the impact of the 2013 ACC/AHA cholesterol guidelines on current U.S. cardiovascular practice. They assessed current practice patterns as a function of the 2013 cholesterol guidelines using the National Cardiovascular Data Registry Practice Innovation and Clinical Excellence registry data.

The researchers found that 96.1 percent among a cohort of 1,174,545 patients were statin-eligible (91.2 percent atherosclerotic cardiovascular disease [ASCVD]; 6.6 percent diabetes; 0.3 percent off-treatment low-density lipoprotein cholesterol ≥190 mg/dL; 1.9 percent estimated 10-year ASCVD risk ≥7.5 percent). Overall, 32.4 percent of patients were not receiving statin therapy and 22.6 percent were receiving non-statin therapies. A total of 20.8 percent of patients had two or more low-density lipoprotein cholesterol assessments during the study period, and 7.0 percent had more than four assessments.

"Achieving concordance with the new cholesterol guidelines in patients treated in U.S. cardiovascular practices would result in significant increases in statin use, as well as significant reductions in non-statin therapies and laboratory testing," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »